Page last updated: 2024-08-17

edetic acid and Minimal Disease, Residual

edetic acid has been researched along with Minimal Disease, Residual in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Arafkas, M; Bania, J; Khosrawipour, T; Khosrawipour, V; Kulas, J; Migdal, P; Pigazzi, A; Schubert, J1
Bellò, M; Ceci, F; Cerio, I; Deandreis, D; Dionisi, B; Finessi, M; Nicolotti, DG; Pilati, E; Zotta, M1
Afshar-Oromieh, A; Barbato, F; Briganti, A; Calais, J; Cervati, V; Eiber, M; Fanti, S; Farolfi, A; Fendler, WP; Gafita, A; Haberkorn, U; Hadaschik, B; Herrmann, K; Ilhan, H; Pianori, D; Spohn, F; Walz, J; Weber, M; Wetter, A1
Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF1

Trials

1 trial(s) available for edetic acid and Minimal Disease, Residual

ArticleYear
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

    Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium

1999

Other Studies

3 other study(ies) available for edetic acid and Minimal Disease, Residual

ArticleYear
Evaluation of Cell-detaching Effect of EDTA in Combination with Oxaliplatin for a Possible Application in HIPEC After Cytoreductive Surgery: A Preliminary in-vitro Study.
    Current pharmaceutical design, 2019, Volume: 25, Issue:45

    Topics: Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Edetic Acid; HT29 Cells; Humans; Hyperthermia, Induced; Neoplasm Recurrence, Local; Neoplasm, Residual; Oxaliplatin; Peritoneal Neoplasms

2019
68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:3

    Topics: Aged; Disease Progression; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Humans; Male; Neoplasm, Residual; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence

2020
    The Journal of urology, 2019, Volume: 202, Issue:6

    Topics: Aged; Biomarkers, Tumor; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Oligopeptides; Positron-Emission Tomography; Predictive Value of Tests; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies

2019